SHG — Singular Health Income Statement
0.000.00%
Last trade - 00:00- AU$90.51m
- AU$76.83m
- AU$0.70m
- 36
- 13
- 58
- 27
Annual income statement for Singular Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.461 | 0.425 | 0.446 | 0.946 | 0.702 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.45 | 6.34 | 4.98 | 4.03 | 6.95 |
| Operating Profit | -2.99 | -5.91 | -4.53 | -3.08 | -6.25 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -4.46 | -5.99 | -4.97 | -2.88 | -6.26 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.46 | -5.99 | -4.97 | -2.88 | -6.26 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -4.46 | -5.99 | -5.39 | -4.92 | -6.38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.46 | -5.99 | -5.39 | -4.92 | -6.38 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.062 | -0.058 | -0.044 | -0.018 | -0.026 |